Recent studies reveal TRE’s potential to enhance mitochondrial function and autophagy in neurodegenerative diseases, while highlighting risks for advanced Huntington’s patients. Emerging r...
New research explores how fasting may improve mitochondrial function and reduce oxidative stress in Huntington’s disease, with implications for other neurodegenerative conditions. Recent clinica...
Exploring how lion’s mane, reishi, and cordyceps mushrooms enhance brain function through unique neuroprotective mechanisms and synergistic nootropic combinations. Cutting-edge research reveals ...
A proposed 12-week clinical trial explores time-restricted eating’s potential benefits on mitochondrial function, autophagy, and cognitive performance in early-stage Huntington’s disease p...
A 12-week clinical trial explores time-restricted eating’s potential benefits for mitochondrial function and cognition in Huntington’s disease patients. Groundbreaking study investigates T...
A new UCSF clinical trial explores time-restricted eating’s neuroprotective potential in Huntington’s disease, building on recent mitochondrial function research. Researchers at UCSF are t...
A 12-week TRE intervention for HD patients demonstrates potential benefits for mitochondrial function and autophagy, though recruitment challenges persist. New research explores how time-restricted ea...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A groundbreaking clinical trial investigates time-restricted eating for Huntington’s disease, exploring neuroprotective mechanisms and practical implementation for patients. The TREAT-HD trial e...
A 12-week clinical trial evaluates the safety and feasibility of time-restricted eating in early-stage Huntington’s disease, focusing on metabolic outcomes and disease biomarkers. A new clinical...
